Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 4 de 4
Filtrar
Mais filtros










Intervalo de ano de publicação
1.
Zhonghua Lao Dong Wei Sheng Zhi Ye Bing Za Zhi ; 37(12): 921-925, 2019 Dec 20.
Artigo em Chinês | MEDLINE | ID: mdl-31937034

RESUMO

Objective: To analysis pathogenic conditions and pathogenic characteristics of organic fluorosis caused by applying of anti-fingerprint coating material on touch screen glass of the mobile phone. Methods: To collect clinical data and analyze the causes and pathogenic characteristics of poisoning through surveying occupational health, detecting occupational hazards in the workplace, collecting clinical data and diagnosing of occupational diseases. 6 employees in workshop 1 of packaging were as the organic fluorine exdposed group, and 16 employees in other workshops were as the non-exposed group. Results: Organic fluorine chemicals (perfluoro-1, 3-dimethylcyclohexane, hexadecafluoroheptane, perfluoro-hexane, perfluoromethy lopentane, perfluoro-2-methyl-2-pentene, etc.) can be volatilized by spraying and baking of anti-fingerprint nano-coating material on touch screen. The relative percentage of volatile components in air is 85.65%. Four cases of acute poisoning were caused by organic fluorosis deposited in a dustless air conditioning workshop with poor ventilation.The clinical manifestations of the patients were acute bronchitis, pulmonary edema and/or myocarditis. The average concentration of urine fluorine in the organic fluorine exposed group was 13.7± 4.4 mmol/mol creatinine, which was 4-5 times higher than that of other non-organic fluorine exposed groups. The difference of urine fluorine level between the organic fluorine exposed group and non exposed group was statistically significant (P<0.01) . The main indicators were abnormal for the blood oxygen saturation of finger pulse under suction air, leukocytes, neutrophils, monocytes, hypersensitivec-reactive protein, procalcitonin, l-lactate dehydrogenase, forebrain diuretic natriuretic peptide, hypersensitive troponin T in the four cases. One case was myocardial ischemia, four cases had bilateral lung symmetrically exudative lesions, one case was accompanied by a small amount of pleural pericardial effusion. Conclusion: Acute organofluorine poisoning can caused by the applying of the fingerprint nano-coating material on touch screen of the mobile phone. Attention should be paid to occupational poisoning caused by the applying of the small molecular perfluoroalkanes (olefins) in new industries, new processes and new materials.


Assuntos
Flúor/efeitos adversos , Doenças Profissionais/induzido quimicamente , Compostos Orgânicos/efeitos adversos , Flúor/urina , Humanos
2.
Braz J Med Biol Res ; 46(8): 670-5, 2013 Aug.
Artigo em Inglês | MEDLINE | ID: mdl-23969976

RESUMO

Ziyuglycoside II is an active compound of Sanguisorba officinalis L. that has anti-inflammation, antioxidation, antibiosis, and homeostasis properties. We report here on the anticancer effect of ziyuglycoside II on human gastric carcinoma BGC-823 cells. We investigated the effects of ziyuglycoside II on cell growth, cell cycle, and cell apoptosis of this cell line. Our results revealed that ziyuglycoside II could inhibit the proliferation of BGC-823 cells by inducing apoptosis but not cell cycle arrest, which was associated with regulation of Bax/Bcl-2 expression, and activation of the caspase-3 pathway. Our study is the first to report the antitumor potential of ziyuglycoside II in BGC-823 gastric cancer cells. Ziyuglycoside II may become a potential therapeutic agent against gastric cancer in the future.


Assuntos
Apoptose/efeitos dos fármacos , Caspase 3/metabolismo , Proteínas Proto-Oncogênicas c-bcl-2/metabolismo , Saponinas/farmacologia , Transdução de Sinais/efeitos dos fármacos , Proteína X Associada a bcl-2/metabolismo , Antineoplásicos/farmacologia , Carcinoma/tratamento farmacológico , Caspase 3/efeitos dos fármacos , Inibidores de Caspase/metabolismo , Ciclo Celular/efeitos dos fármacos , Linhagem Celular Tumoral , Proliferação de Células/efeitos dos fármacos , Fluorometria , Fluoruracila/farmacologia , Humanos , Proteínas Proto-Oncogênicas c-bcl-2/efeitos dos fármacos , Sanguisorba/química , Neoplasias Gástricas/tratamento farmacológico , Proteína X Associada a bcl-2/efeitos dos fármacos
3.
Braz. j. med. biol. res ; 46(8): 670-675, ago. 2013. tab, graf
Artigo em Inglês | LILACS | ID: lil-684531

RESUMO

Ziyuglycoside II is an active compound of Sanguisorba officinalis L. that has anti-inflammation, antioxidation, antibiosis, and homeostasis properties. We report here on the anticancer effect of ziyuglycoside II on human gastric carcinoma BGC-823 cells. We investigated the effects of ziyuglycoside II on cell growth, cell cycle, and cell apoptosis of this cell line. Our results revealed that ziyuglycoside II could inhibit the proliferation of BGC-823 cells by inducing apoptosis but not cell cycle arrest, which was associated with regulation of Bax/Bcl-2 expression, and activation of the caspase-3 pathway. Our study is the first to report the antitumor potential of ziyuglycoside II in BGC-823 gastric cancer cells. Ziyuglycoside II may become a potential therapeutic agent against gastric cancer in the future.


Assuntos
Humanos , Apoptose/efeitos dos fármacos , /metabolismo , /metabolismo , Saponinas/farmacologia , Transdução de Sinais/efeitos dos fármacos , /metabolismo , Antineoplásicos/farmacologia , Linhagem Celular Tumoral , Carcinoma/tratamento farmacológico , /efeitos dos fármacos , Inibidores de Caspase/metabolismo , Ciclo Celular/efeitos dos fármacos , Proliferação de Células/efeitos dos fármacos , Fluorometria , Fluoruracila/farmacologia , /efeitos dos fármacos , Sanguisorba/química , Neoplasias Gástricas/tratamento farmacológico , /efeitos dos fármacos
4.
Int J Pharm ; 301(1-2): 217-25, 2005 Sep 14.
Artigo em Inglês | MEDLINE | ID: mdl-16040213

RESUMO

Poly(D,L-lactide-co-glycolide) (PLG) biodegradable microspheres containing a contraceptive drug, levonorgestrel (LNG), were prepared using both the solvent evaporation method and a modified solvent extraction-evaporation method. The microspheres prepared with the solvent evaporation process had porous surfaces with low product yields and poor encapsulation efficiencies. On the other hand, the microspheres prepared using the modified solvent extraction-evaporation method were nonporous with encapsulation efficiencies close to 100%. In vitro drug release showed the nonporous microspheres had a lower initial burst and a slightly prolonged duration of release than those porous microspheres. In vivo release kinetics of the low burst microspheres were determined by measuring LNG plasma levels after a single intramuscular injection to female rats. At a LNG dose of 41.1 mg/kg, average plasma LNG levels were 6-10 ng/ml in the first 24 h and subsequently remained above 1 ng/ml until 126 days. The duration above the minimum effective LNG plasma level of 0.2 ng/ml was 168 days. By comparison, a similar dose of LNG microcrystals used as control produced a much higher plasma level of 15-21 ng/ml in the first day followed by a fast and continuous decline of LNG levels with a duration of only about 35 days.


Assuntos
Anticoncepcionais Femininos/química , Anticoncepcionais Femininos/farmacocinética , Ácido Láctico/química , Levanogestrel/química , Levanogestrel/farmacocinética , Ácido Poliglicólico/química , Polímeros/química , Animais , Clorofórmio/análise , Anticoncepcionais Femininos/administração & dosagem , Preparações de Ação Retardada , Feminino , Injeções Intramusculares , Levanogestrel/administração & dosagem , Microscopia Eletrônica de Varredura , Microesferas , Tamanho da Partícula , Copolímero de Ácido Poliláctico e Ácido Poliglicólico , Ratos , Ratos Sprague-Dawley
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA
...